Pediatric Endocrinology Diabetes and Metabolism

Abstract

4/2021 vol. 27
Case report

To increase body height and muscle strength – one medicine for two diseases? Case report of a boy with Silver-Russell syndrome and Duchenne muscular dystrophy

  1. Department of Endocrinology and Diabetology of the Developmental Age, Medical University of Wroclaw, Poland
  2. Student Scientific Club at the Department of Endocrinology and Diabetology of the Developmental Age, Medical University of Wroclaw, Poland
Pediatr Endocrinol Diabetes Metab 2021; 27 (4): 298–304
Online publish date: 2021/12/14
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
The coexistence of 2 genetic diseases can mutually modify their course. We describe the case of a 10-year-old boy with Sliver-Russell syndrome (SRS) and Duchenne muscular dystrophy (DMD). The patient's short stature, which is part of the clinical picture of both diseases, has been additionally aggravated by the steroid therapy, which is necessary to delay the progression of DMD. From the age of 9 years, the patient was treated with recombinant human growth hormone (rhGH) for 18 months. The following study discusses whether rhGH therapy in a child with SRS and DMD may alleviate or worsen the course of DMD, and how it affects carbohydrate metabolism disorders.
Share
without publication fees